arrow
É

Éric Thouvenot

centre hospitalier universitaire de nimes
H指数:53
被引数:8,625

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study

κ游离轻链指数或寡克隆带检测在多发性硬化诊断中的临床应用:一种算法比较研究

2026-05-060
PRE
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examination

使用数字神经学检查比较放射孤立综合征个体、早期多发性硬化患者和健康对照者

2026-02-220
PRE
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis The D-Lay MS Randomized Clinical Trial

高剂量维生素D在临床孤立综合征中的效果研究——D-Lay MS随机临床试验

2025-04-221
PRE
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population

多发性硬化女性患者的妊娠及分娩结局:RESPONSE研究对比法国普通人群

2025-03-180
PRE
MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS

NMOSD和MOGAD的MRI管理: 法国专家组NOMADMUS的建议

2025-02-011
PRE
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France

法国多发性硬化症患者的教育水平与获得疾病改善治疗之间的关联

2024-12-010
PRE
Association between education level and disability progression in patients with multiple sclerosis in France

法国多发性硬化症患者的教育水平与残疾进展之间的关联

2024-11-300
PRE
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults
2024-08-132
PRE
Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS A Comparative Study
2024-07-234
PRE
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
2024-02-152
PRE
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

多发性硬化症患者的新型冠状病毒肺炎结局: 了解2022年2020年变化

2024-01-211
OA
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
2023-06-2315
OAAI
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study
2023-06-152
OA
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
2023-05-017
OAAI